Product Images Crestor
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Crestor NDC 43353-290 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Rosuvastatin Calcium (Crestor) is a medication available in the form of 40mg 15 tablets. The manufacturer is IPR Pharmaceuticals, Inc. and repackaged by Aphen Pharma. The storage condition required for this medication is between 20.25 degrees C (877 degrees F) and it should be kept away from children. The medication batch number marked as P290Z and NDC# is 43353-0031-15.*
Rosuvastatin Calcium (Crestor) is a medication available in the form of 20mg tablets. This package includes 15 tablets and has a National Drug Code (NDC) of 43353-0289-15. Keep the medication in a controlled room temperature between 20-25 degrees Celsius, and out of the reach of children. This medication is manufactured by IPR Pharmaceuticals in Carolina, PR and repackaged by Aphen Pharma in Cookeville, TH. Batch number P290Z is also provided.*
This is a description of a medication called Rosuvastatin Calcium, specifically the 10mg 15 tablet package under the brand name Crestor. The manufacturer is listed as IPR Pharmaceuticals, Inc from Carolina, PR. The medication should be stored at a temperature between 20.25 degrees C and protected in a USP container. It warns to keep the medication away from children. Lastly, it was repackaged by Aphen Pharma in Cookeville, TN under Batch P290Z.*
This appears to be statistical data related to the incidence of an event, possibly in a clinical trial. The top section indicates a cumulative incidence percentage, and the middle section includes a hazard ratio and related statistical values. The final section displays the number at risk and years elapsed. Without additional context or information about what event is being measured, it is difficult to provide a more specific description.*
This is a table showing the number of events and related statistics for two groups of participants (Roswa2omg and Placebo2omg) in a clinical trial. The data includes the primary endpoint and various other outcomes related to cardiovascular events. The "HR" and "HazwdRato" columns may represent hazard ratios or other statistical measures.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.